| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 28, 2006
Revised on October 4, 2006
Accepted on October 4, 2006
1-Adrenergic but Locally Confined
2-Adrenergic Receptor-Mediated Signaling
From the Institute of Pharmacology and Toxicology (V.O.N., M.B., E.S., M.J.L.), University of Wuerzburg; and Rudolf-Virchow-Center (S.E.), Deutsche Forschungsgemeinschaft-Research Center for Experimental Biomedicine, University of Wuerzburg, Germany.
* To whom correspondence should be addressed. E-mail: stefan.engelhardt{at}virchow.uni-wuerzburg.de.
1- and
2-adrenergic receptors (
ARs) are known to differentially regulate cardiomyocyte contraction and growth. We tested the hypothesis that these differences are attributable to spatial compartmentation of the second messenger cAMP. Using a fluorescent resonance energy transfer (FRET)-based approach, we directly monitored the spatial and temporal distribution of cAMP in adult cardiomyocytes. We developed a new cAMP-FRET sensor (termed HCN2-camps) based on a single cAMP binding domain of the hyperpolarization activated cyclic nucleotide-gated potassium channel 2 (HCN2). Its cytosolic distribution, high dynamic range, and sensitivity make HCN2-camps particularly well suited to monitor subcellular localization of cardiomyocyte cAMP. We generated HCN2-camps transgenic mice and performed single-cell FRET imaging on freshly isolated cardiomyocytes. Whole-cell superfusion with isoproterenol showed a moderate elevation of cAMP. Application of various phosphodiesterase (PDE) inhibitors revealed stringent control of cAMP through PDE4>PDE2>PDE3. The
1AR-mediated cAMP signals were entirely dependent on PDE4 activity, whereas
2AR-mediated cAMP was under control of multiple PDE isoforms.
1AR subtype-specific stimulation yielded
2-fold greater cAMP responses compared with selective
2-subtype stimulation, even on treatment with the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX) (
FRET, 8.8±0.4% [
2AR] versus 17.3±1.3% [
1AR]). Treatment with pertussis toxin to inactivate Gi did not affect cAMP production. Localized
1AR stimulation generated a cAMP gradient propagating throughout the cell, whereas local
2AR stimulation did not elicit marked cAMP diffusion. Our data reveal that in adult cardiac myocytes,
1ARs induce far-reaching cAMP signals, whereas
2AR-induced cAMP remains locally confined.
-adrenergic receptor
Related Article:
This article has been cited by other articles:
![]() |
F. Vandeput, J. Krall, R. Ockaili, F. N. Salloum, V. Florio, J. D. Corbin, S. H. Francis, R. C. Kukreja, and M. A. Movsesian cGMP-Hydrolytic Activity and Its Inhibition by Sildenafil in Normal and Failing Human and Mouse Myocardium J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 884 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Soto, V. De Arcangelis, J. Zhang, and Y. Xiang Dynamic Protein Kinase A Activities Induced by {beta}-Adrenoceptors Dictate Signaling Propagation for Substrate Phosphorylation and Myocyte Contraction Circ. Res., March 27, 2009; 104(6): 770 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. De Arcangelis, D. Soto, and Y. Xiang Phosphodiesterase 4 and Phosphatase 2A Differentially Regulate cAMP/Protein Kinase A Signaling for Cardiac Myocyte Contraction under Stimulation of {beta}1 Adrenergic Receptor Mol. Pharmacol., November 1, 2008; 74(5): 1453 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Iancu, G. Ramamurthy, S. Warrier, V. O. Nikolaev, M. J. Lohse, S. W. Jones, and R. D. Harvey Cytoplasmic cAMP concentrations in intact cardiac myocytes Am J Physiol Cell Physiol, August 1, 2008; 295(2): C414 - C422. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kass Message Delivered: How Myocytes Control cAMP Signaling Circ. Res., May 9, 2008; 102(9): 1002 - 1004. [Full Text] [PDF] |
||||
![]() |
J. Leroy, A. Abi-Gerges, V. O. Nikolaev, W. Richter, P. Lechene, J.-L. Mazet, M. Conti, R. Fischmeister, and G. Vandecasteele Spatiotemporal Dynamics of {beta}-Adrenergic cAMP Signals and L-Type Ca2+ Channel Regulation in Adult Rat Ventricular Myocytes: Role of Phosphodiesterases Circ. Res., May 9, 2008; 102(9): 1091 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsujikawa, Y. Song, M. Watanabe, H. Masumiya, S. A. Gupte, R. Ochi, and T. Okada Cholesterol depletion modulates basal L-type Ca2+ current and abolishes its -adrenergic enhancement in ventricular myocytes Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H285 - H292. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Willoughby, G. S. Baillie, M. J. Lynch, A. Ciruela, M. D. Houslay, and D. M. F. Cooper Dynamic Regulation, Desensitization, and Cross-talk in Discrete Subcellular Microdomains during beta2-Adrenoceptor and Prostanoid Receptor cAMP Signaling J. Biol. Chem., November 23, 2007; 282(47): 34235 - 34249. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vandeput, S. L. Wolda, J. Krall, R. Hambleton, L. Uher, K. N. McCaw, P. B. Radwanski, V. Florio, and M. A. Movsesian Cyclic Nucleotide Phosphodiesterase PDE1C1 in Human Cardiac Myocytes J. Biol. Chem., November 9, 2007; 282(45): 32749 - 32757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zaccolo and M. A. Movsesian cAMP and cGMP Signaling Cross-Talk: Role of Phosphodiesterases and Implications for Cardiac Pathophysiology Circ. Res., June 8, 2007; 100(11): 1569 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Houslay, G. S. Baillie, and D. H. Maurice cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling Circ. Res., April 13, 2007; 100(7): 950 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Merkle, S. Frantz, M. P. Schon, J. Bauersachs, M. Buitrago, R. J.A. Frost, E. M. Schmitteckert, M. J. Lohse, and S. Engelhardt A Role for Caspase-1 in Heart Failure Circ. Res., March 16, 2007; 100(5): 645 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. DiPilato and J. Zhang FRETting Mice Shed Light on Cardiac Adrenergic Signaling Circ. Res., November 10, 2006; 99(10): 1021 - 1023. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |